28 research outputs found
Behavioral and neurochemical assessment of the role of ERK pathway in the psychopharmacological effects of ethanol, caffeine and of their interaction
The intracellular signaling cascades constitute the means by which addictive substances induce the remodeling of the circuits involved in motivated behaviors which underlie the learning processes and the development of memories at the basis of the progression of addiction. A molecule protagonist in such signaling cascades is the Extracellular signal-Regulated Kinase (ERK), a member of the mitogen-activated protein kinase, that constitutes an important biochemical factor common to many cellular functions. The abundant expression of ERK in brain areas of the addiction circuits emphasizes the relevance of these kinases in modulating behavioral functions mediated by these circuits. Thus, the general aim of the present doctoral thesis was to study the role of ERK in terms of protein kinase expression and behavioral responses induced by ethanol, caffeine and their association. The first and second chapters examined the involvement of protein kinases ERK in different aspects of ethanol-induced place conditioning. Specifically, in the first chapter we used the MEK inhibitor SL327 to study how the blockade of this cascade could affect the acquisition and expression of Conditioned Place Preference (CPP) and Conditioned Place Aversion (CPA) elicited by ethanol. The second chapter explored the results of the pharmacological relationship between caffeine and ethanol in ethanol-elicited CPP and CPA. In this chapter we also investigated the expression of pERK as a result of 1) the acute administration of both substances and 2) the presentation of stimuli positively (CPP) or negatively (CPA) conditioned to ethanol. The last chapter examines the pharmacological relationship between caffeine and ethanol through the analysis of horizontal and vertical locomotion and evaluated whether there was reciprocal cross-sensitization with respect to these effects. We also examined the phosphorylation of DARPP-32(Thr75), another factor of intracellular signaling cascade, and of ERK in the nucleus accumbens. The findings of these studies revealed that MEK/ERK pathway is differentially involved in distinct phases of associative learning behavior expressed in the CPP and CPA elicited by ethanol. Moreover, our data disclose that ERK activation takes place differentially in distinct brain regions depending on the motivational significance of the conditioned stimulus. Furthermore, we demonstrated that caffeine significantly impaires ethanol-elicited place conditioning (both CPP and CPA) and prevents ethanol-induced pERK expression in several brain areas with different activation patterns depending on the brain area examined. Our observations also revealed that caffeine and ethanol affect horizontal and vertical locomotion in different manner and without undergoing cross-sensitization. Finally, caffeine prevents ethanol-elicited pERK expression in the nucleus accumbens whereas there were no effects on pDARPP-32(Thr75).
Taken together the results of the present thesis offer new insights into the complexity of the involvement of ERK cascade in the acquisition and expression of associative learning and provide new information about the antagonistic interaction between caffeine and ethanol expressed in place conditioning and locomotor activation
Ethanol-Dependent Synthesis of Salsolinol in the Posterior Ventral Tegmental Area as Key Mechanism of Ethanol’s Action on Mesolimbic Dopamine
Abnormal consumption of ethanol, the ingredient responsible for alcoholic drinks’
addictive liability, causes millions of deaths yearly. Ethanol’s addictive potential is
triggered through activation, by a still unknown mechanism, of the mesolimbic dopamine
(DA) system, part of a key motivation circuit, DA neurons in the posterior ventral
tegmental area (pVTA) projecting to the ipsilateral nucleus accumbens shell (AcbSh).
The present in vivo brain microdialysis study, in dually-implanted rats with one probe
in the pVTA and another in the ipsilateral or contralateral AcbSh, demonstrates this
mechanism. As a consequence of the oral administration of a pharmacologically
relevant dose of ethanol, we simultaneously detect a) in the pVTA, a substance,
1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol), untraceable under
control conditions, product of condensation between DA and ethanol’s first by-product,
acetaldehyde; and b) in the AcbSh, a significant increase of DA release. Moreover, such
newly generated salsolinol in the pVTA is responsible for increasing AcbSh DA release
via m opioid receptor (mOR) stimulation. In fact, inhibition of salsolinol’s generation
in the pVTA or blockade of pVTA mORs prevents ethanol-increased ipsilateral, but
not contralateral, AcbSh DA release. This evidence discloses the long-sought key
mechanism of ethanol’s addictive potential and suggests the grounds for developing
preventive and therapeutic strategies against abnormal consumption
Inhibition of Morphine- and Ethanol-Mediated Stimulation of Mesolimbic Dopamine Neurons by Withania somnifera
Morphine- and ethanol-induced stimulation of neuronal firing of ventral tegmental
area (VTA) dopaminergic neurons and of dopamine (DA) transmission in the shell
of the nucleus accumbens (AcbSh) represents a crucial electrophysiological and
neurochemical response underlying the ability of these compounds to elicit motivated
behaviors and trigger a cascade of plasticity-related biochemical events. Previous
studies indicate that the standardized methanolic extract of Withania somnifera roots
(WSE) prevents morphine- and ethanol-elicited conditioned place preference and oral
ethanol self-administration. Aim of the present research was to investigate whether
WSE may also interfere with the ability of morphine and ethanol to stimulate VTA
dopaminergic neurons and thus AcbSh DA transmission as assessed in male Sprague-
Dawley rats by means of patch-clamp recordings in mesencephalic slices and
in vivo brain microdialysis, respectively. Morphine and ethanol significantly stimulated
spontaneous firing rate of VTA neurons and DA transmission in the AcbSh. WSE, at
concentrations (200–400 mg/ml) that significantly reduce spontaneous neuronal firing
of VTA DA neurons via a GABAA- but not GABAB-mediated mechanism, suppressed
the stimulatory actions of both morphine and ethanol. Moreover, in vivo administration
of WSE at a dose (75 mg/kg) that fails to affect basal DA transmission, significantly
prevented both morphine- and ethanol-elicited increases of DA in the AcbSh. Overall,
these results highlight the ability of WSE to interfere with morphine- and ethanolmediated
central effects and suggest a mechanistic interpretation of the efficacy of this
extract to prevent the motivational properties of these compounds
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
Effects of caffeine on ethanol-elicited place preference, place aversion and ERK phosphorylation in CD-1 mice
Background:
Epidemiological studies indicate a rise in the combined consumption of caffeinated and alcoholic beverages, which can lead to increased risk of alcoholic-beverage overconsumption. However, the effects of the combination of caffeine and ethanol in animal models related to aspects of drug addiction are still underexplored.
Aims:
To characterize the pharmacological interaction between caffeine and ethanol and establish if caffeine can affect the ability of ethanol (2 g/kg) to elicit conditioned place preference and conditioned place aversion, we administered caffeine (3 or 15 mg/kg) to male CD-1 mice before saline or ethanol. Moreover, we determined if these doses of caffeine could affect ethanol (2 g/kg) elicited extracellular signal-regulated kinase phosphorylation in brain areas, nucleus accumbens, bed nucleus of stria terminalis, central nucleus of the amygdala, and basolateral amygdala, previously associated with this type of associative learning.
Results:
In the place-conditioning paradigm, caffeine did not have an effect on its own, whereas ethanol elicited significant conditioned-place preference and conditioned-place aversion. Caffeine (15 mg/kg) significantly prevented the acquisition of ethanol-elicited conditioned-place preference and, at both doses, also prevented the acquisition of ethanol-elicited conditioned-place aversion. Moreover, both doses of caffeine also prevented ethanol-elicited extracellular signal-regulated kinase phosphorylation expression in all brain areas examined.
Conclusions:
The present data indicate a functional antagonistic action of caffeine and ethanol on associative learning and extracellular signal-regulated kinase phosphorylation after an acute interaction. These results could provide exciting grounds for further studies, also in a translational perspective, of their pharmacological interaction modulating other processes involved in drug consumption and addiction
New insights on the effects of Withania somnifera on the motivational properties of addictive drugs
Introduction: Withania somnifera Dunal, known as Ashwagandha or Indian ginseng, has long been used in Ayurvedic medicine for its anti-inflammatory and immunomodulatory properties. Recent studies demonstrated its neuroprotective effects in experimental models of neurodegenerative disorders, including Parkinson disease and the standardized methanolic extract of Withania somnifera Dunal roots (WSE) has been shown to interact with some of the psychopharmacological effects of morphine and ethanol. In particular, WSE prevents the acquisition and expression of morphine-elicited conditioned place preference (CPP) and, in mice chronically treated with morphine, could prevent the development of tolerance and dependence. In addition, chronic administration of WSE during chronic treatment with morphine could prevent the drastic reduction of dendritic spine density in the rat nucleus accumbens (NAc) shell upon spontaneous and naloxone-precipitated withdrawal. Moreover, WSE may also reduce ethanol withdrawal-induced anxiety, potentiate ethanol-induced anxiolysis and impair acquisition and maintenance of ethanol self-administration under both fixed and progressive ratios and acquisition and expression of ethanol-elicited CPP.
Morphine and ethanol increase dopamine (DA) transmission and elicit Extracellular signal Regulated Kinase phosphorylation (pERK) in the NAc, effects that have been suggested as neurochemical and molecular measures of their addictive properties.
The aim of the present research was to characterize the effects of WSE on morphine- (5 mg/kg) and ethanol- (1 g/kg) and elicited DA transmission in the NAc shell of male Sprague-Dawley (SD) rats as well as on those of morphine (10 mg/kg)- and ethanol (2 g/kg) elicited ERK phosphorylation in the NAc shell and core of CD-1 mice.
Methods: DA transmission in the NAc shell of SD rats (280-320 g) was monitored by in vivo brain microdialysis technique; standard pERK immunodetection assay was applied to 40 µm-thick sections of mice forebrain (NAc).
Results: WSE (75 mg/kg) administration significantly reduces morphine (5 mg/kg)- and completely blocks ethanol (1 g/kg)-elicited increases of DA transmission in the NAc shell. Furthermore WSE administration (50 mg/kg) significantly reduces morphine (10 mg/kg)- and ethanol (2 g/kg)-elicited ERK-phosphorylation in the NAc shell and NAc core.
Conclusions: The observation that WSE significantly affects the increases of DA transmission in the NAc shell of SD rats induced by morphine and ethanol confirms the ability of WSE to interfere with their central effects and suggests a possible mechanism by which WSE impairs morphine and ethanol motivational properties. This interpretation is further supported by the observation that WSE also significantly affects morphine- and ethanol-elicited ERK-phosphorylation in the same area.
Taken together these results point to Withania somnifera as an interesting plant for further studies aimed at characterizing its potential application for prevention and/or treatment of drug dependence
Impact of Caffeine on Ethanol-Induced Stimulation and Sensitization: Changes in ERK and DARPP-32 Phosphorylation in Nucleus Accumbens
Background
Caffeine is frequently consumed with ethanol to reduce the impairing effects induced by ethanol, including psychomotor slowing or incoordination. Both drugs modulate dopamine (DA)‐related markers in accumbens (Acb), and Acb DA is involved in voluntary locomotion and locomotor sensitization. The present study determined whether caffeine can affect locomotion induced by acute and repeated ethanol administration in adult male CD‐1 mice.
Methods
Acute administration of caffeine (7.5 to 30.0 mg/kg) was evaluated for its effects on acute ethanol‐induced (1.5 to 3.5 g/kg) changes in open‐field horizontal locomotion, supported rearing, and rearing not supported by the wall. DA receptor‐dependent phosphorylation markers were assessed: extracellular signal‐regulated kinase (pERK), and dopamine‐and cAMP‐regulated phosphoprotein Mr32kDa phosphorylated at threonine 75 site (pDARPP‐32‐Thr75) in Acb core and shell. Acutely administered caffeine was also evaluated in ethanol‐sensitized (1.5 g/kg) mice.
Results
Acute ethanol decreased both types of rearing. Caffeine increased supported rearing but did not block ethanol ‐induced decreases in rearing. Both substances increased horizontal locomotion in a biphasic manner, and caffeine potentiated ethanol‐induced locomotion. Although ethanol administered repeatedly induced sensitization of locomotion and unsupported rearing, acute administration of caffeine to ethanol‐sensitized mice in an ethanol‐free state resulted in blunted stimulant effects compared with those seen in ethanol‐naïve mice. Ethanol increased pERK immunoreactivity in both subregions of the Acb, but coadministration with caffeine blunted this increase. There were no effects on pDARPP‐32(Thr75) immunoreactivity.
Conclusions
The present results demonstrated that, after the first administration, caffeine potentiated the stimulating actions of ethanol, but did not counteract its suppressant or ataxic effects. Moreover, our results show that caffeine has less activating effects in ethanol‐sensitized animals
Differential effects of the MEK inhibitor SL327 on the acquisition and expression of ethanol-elicited conditioned place preference and aversion in mice
The involvement of mitogen-activating extracellular kinase (MEK) in place conditioning may vary depending on the motivational sign (positive or negative) and nature (pharmacological or nociceptive) of the unconditioned stimulus (US) and on the phase (acquisition or expression) of the learning process. This study investigated the role of MEK on the acquisition and expression of ethanol-elicited (given 2 g/kg) backward (preference, CPP) and forward (aversion, CPA) place conditioning. The MEK inhibitor SL327 (50 mg/kg for CPP, and 50 and 100 mg/kg for CPA) was administered to CD-1 mice 60 minutes before an ethanol dose (acquisition) or 60 minutes before the post-conditioning tests (expression). Ethanol significantly elicited CPP and CPA; SL327 (50 mg/kg) significantly blocked the acquisition of ethanol-elicited CPP, but not that of CPA. Moreover, SL327 (50 and 100 mg/kg) significantly reduced the expression of ethanol-elicited CPP, but not that of CPA. Finally, SL327 also prevented ethanol-elicited (given 2 g/kg) increases of phosphorylated extracellular signal regulated kinase (pERK)-positive neurons in the nucleus accumbens and other nuclei of the extended amygdala. Overall, these results confirmed the differential involvement of MEK in the acquisition and expression of drug-elicited place conditioning and suggested its differential involvement in distinct behavioral outcomes, depending on the motivational sign of the (same) US and on the significance of the experimental phase of the learning process
Effects of caffeine on ethanol-elicited place preference, place aversion and ERK phosphorylation in CD-1 mice
Background: Epidemiological studies indicate a rise in the combined consumption of caffeinated and alcoholic beverages, which can lead to increased risk of alcoholic-beverage overconsumption. However, the effects of the combination of caffeine and ethanol in animal models related to aspects of drug addiction are still underexplored.
Aims: To characterize the pharmacological interaction between caffeine and ethanol and establish if caffeine can affect the ability of ethanol (2 g/kg) to elicit conditioned place preference and conditioned place aversion, we administered caffeine (3 or 15 mg/kg) to male CD-1 mice before saline or ethanol. Moreover, we determined if these doses of caffeine could affect ethanol (2 g/kg) elicited extracellular signal-regulated kinase phosphorylation in brain areas, nucleus accumbens, bed nucleus of stria terminalis, central nucleus of the amygdala, and basolateral amygdala, previously associated with this type of associative learning.
Results: In the place-conditioning paradigm, caffeine did not have an effect on its own, whereas ethanol elicited significant conditioned-place preference and conditioned-place aversion. Caffeine (15 mg/kg) significantly prevented the acquisition of ethanol-elicited conditioned-place preference and, at both doses, also prevented the acquisition of ethanol-elicited conditioned-place aversion. Moreover, both doses of caffeine also prevented ethanol-elicited extracellular signal-regulated kinase phosphorylation expression in all brain areas examined.
Conclusions: The present data indicate a functional antagonistic action of caffeine and ethanol on associative learning and extracellular signal-regulated kinase phosphorylation after an acute interaction. These results could provide exciting grounds for further studies, also in a translational perspective, of their pharmacological interaction modulating other processes involved in drug consumption and addiction
Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation
RATIONALE:
Despite the critical role attributed to phosphorylated extracellular signal regulated kinase (pERK1/2) in the nucleus accumbens (Acb) in the actions of addictive drugs, the effects of morphine on ERK1/2 phosphorylation in this area are still controversial.
OBJECTIVES:
In order to investigate further this issue, we studied (1) the ability of morphine to affect ERK1/2 phosphorylation in the shell (AcbSh) and core (AcbC) of Sprague-Dawley and Wistar rats and of CD-1 and C57BL/6J mice and (2) the role of dopamine D1 and μ-opioid receptors in Sprague-Dawley rats and CD-1 mice.
METHODS:
The pERK1/2 expression was assessed by immunohistochemistry.
RESULTS:
In rats, morphine decreased AcbSh and AcbC pERK1/2 expression, whereas in mice, increased it preferentially in the AcbSh compared with the AcbC. Systemic SCH 39166 decreased pERK1/2 expression on its own in the AcbSh and AcbC of Sprague-Dawley rats and CD-1 mice; furthermore, in rats, SCH 39166 disclosed the ability of morphine to stimulate pERK1/2 expression. Systemic (rats and mice) and intra-Acb (rats) naltrexone prevented both decreases, in rats, and increases, in mice.
CONCLUSIONS:
These findings confirm the differential effects of morphine in rats and mice Acb and that D1 receptors exert a facilitatory role on ERK1/2 phosphorylation; furthermore, they indicate that, in rats, removal of the D1-dependent pERK1/2 expression discloses the stimulatory influence of morphine on ERK1/2 phosphorylation and that the morphine's ability to decrease pERK1/2 expression is mediated by Acb μ-opioid receptors. Future experiments may disentangle the psychopharmacological significance of the effects of morphine on pERK1/2 in the Ac